Skip to main content
Premium Trial:

Request an Annual Quote

Angle: Juliet Thompson

Angle has appointed Juliet Thompson as a non-executive director of the company, effective Jan. 5, 2023. Thompson has spent much of her career advising companies in the international life sciences sector, completing multiple financing and M&A transactions in Europe and the US and helping companies raise in excess of $4 billion to pursue their growth strategies. She has held senior positions at WestLB, Panmure, and Stifel Europe, and in 2003 was a cofounder of the specialist life science investment bank, Code Securities, later acquired by Nomura. Thompson currently holds a number of roles including non-executive board positions at Indivior, Novacyt SA, and the private company OrganOx. She chairs the audit committees of all three companies and is a member of the remuneration and nomination committees.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find structural network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.